ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Enzychem Files IND for Phase 2 Study of EC-18 in Preventing ARDS Due to COVID-19 Pneumonia
July 22, 2020Enzychem Lifesciences has filed an Investigational New Drug Application (IND) to the US Food and Drug Administration (FDA) for a Phase 2 clinical trial of EC-18 as a preventative therapeutic against Acute Respiratory Disease Syndrome (ARDS) due to ... -
Enzychem Lifesciences announces filing of US provisional patent for EC-18 to treat COVID-19
April 15, 2020Enzychem Lifesciences announced that it has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) covering treating COVID-19 infections and symptoms using EC-18.
Pharma Sources Insight January 2025
